MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 27.12.2025
MorphoSys AG P/B 2011-2026 | MOR
P/B Jährlich MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1.28 | 5.77 | 11.4 | 6.49 | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 11.4 | 1.28 | 6.24 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aclaris Therapeutics
ACRS
|
0.979 | $ 2.68 | - | $ 207 M |  USA |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.21 | - | $ 7.72 B |  Australia |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 213.28 | - | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.95 | - | $ 498 M |  Britain |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | Britain |
 |
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
5.29 | $ 100.08 | - | $ 27.2 B |  Germany |
 |
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 27.33 | -1.05 % | $ 1.32 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 4.71 | -0.21 % | $ 10.2 B |  Israel |
 |
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.428 | $ 10.94 | -1.17 % | $ 720 M | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 11.74 | - | $ 759 M | USA |
 |
BioVie
BIVI
|
0.128 | $ 1.35 | -2.88 % | $ 1.99 M | USA |
 |
Axon Enterprise
AXON
|
17.1 | $ 620.91 | - | $ 47 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.83 | - | $ 17.8 M | USA |
 |
AstraZeneca PLC
AZN
|
2.07 | $ 95.16 | - | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | USA |
 |
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
1.26 | $ 9.29 | - | $ 1.49 B | Britain |
 |
bluebird bio
BLUE
|
0.344 | - | - | $ 546 M | USA |
 |
Biogen
BIIB
|
1.16 | $ 186.91 | - | $ 27.2 B | USA |
 |
Abeona Therapeutics
ABEO
|
10.1 | $ 5.22 | 1.16 % | $ 112 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
2.09 | $ 1.46 | 0.69 % | $ 16.7 M | Israel |
 |
Cellectis S.A.
CLLS
|
0.531 | $ 4.55 | - | $ 116 M | France |